PAVM
PAVmed Inc.
$5.71
-0.59 (-9.37%)
At close · Jul 2
Market Cap
$41.53M
Shares
7,272,739
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.71
Open$6.30
Day$5.71–6.30
52W$3.85–28.44
Avg vol 30d21K
Short int8K · 0.1% float · 1.0d
Short vol21%
Last earningsMay 15, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 14
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Sell
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−40% below
−
Price vs 50-day avg
−10% below
◦
RSI (14)
52 · neutral
+
MACD trend
positive
−
52-week position
8% · near low
Sentiment · smart money
Neutral
◦
Trend (MA cross)
50d $6 › 200d $9 — 200d above 50d
+
Institutional flow
+567% holders QoQ · +18 funds added
◦
Insider flow
No net insider activity over 90 days
−
Short interest
0.12% of float · ▲ +1.4% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
20 holders — 13F breadth
Fundamentals
Fair
+
Revenue growth
+20% Y/Y
◦
Gross margin
-3%
−
EPS growth
−138% Y/Y
−
Free cash flow
$-5.2M
+
Balance sheet
net cash $1.5M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 14, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−40% below
Bearish
Price vs 50-day avg
−10% below
Bearish
RSI (14)
52 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
8% · near low
Bearish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $6 › 200d $9 — 200d above 50d
Institutional flow
Accumulating
+567% holders QoQ · +18 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.12% of float · ▲ +1.4% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
20 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $4
Now $6 · 8%
52-wk high $28
vs 200-day avg -40%
vs 50-day avg -10%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
PAVM
this stock
PAVmed Inc.
|
$41.53M | -13.9% | +20.0% | — | 0.1% |
|
ABT
Abbott Laboratories
|
$166.17B | -23.5% | +5.7% | 26.7 | 1.3% |
|
SYK
Stryker Corp
|
$125.18B | -6.8% | +11.2% | 37.8 | 1.6% |
|
MDT
Medtronic plc
|
$106.49B | -12.7% | +8.4% | 22.3 | 1.4% |
|
BSX
Boston Scientific Corp
|
$67.09B | -52.7% | +5.5% | 18.9 | 2.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| PAVM | +31.3% | -2.1% | -21.7% | -3.9% | -13.9% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +29.8% | -0.9% | -29.7% | -3.6% | -23.1% |